These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23725082)
1. Hypertensive disease of pregnancy is associated with decreased risk for respiratory distress syndrome in moderate preterm neonates. Liu A; Carlsson E; Nilsson S; Oei J; Bajuk B; Peek M; Martin A; Nanan R; Hypertens Pregnancy; 2013 May; 32(2):169-77. PubMed ID: 23725082 [TBL] [Abstract][Full Text] [Related]
2. Mild to Moderate, but Not Minimal or Severe, Acute Histologic Chorioamnionitis or Intra-Amniotic Inflammation Is Associated with a Decrease in Respiratory Distress Syndrome of Preterm Newborns without Fetal Growth Restriction. Park CW; Park JS; Jun JK; Yoon BH Neonatology; 2015; 108(2):115-23. PubMed ID: 26087777 [TBL] [Abstract][Full Text] [Related]
3. Antenatal Corticosteroids for the Prevention of Respiratory Distress Syndrome in Premature Twins. Viteri OA; Blackwell SC; Chauhan SP; Refuerzo JS; Pedroza C; Salazar XC; Sibai BM Obstet Gynecol; 2016 Sep; 128(3):583-91. PubMed ID: 27500336 [TBL] [Abstract][Full Text] [Related]
4. Neonatal outcome of pregnancies complicated by hypertensive disorders between 34 and 37 weeks of gestation: a 7 year retrospective analysis of a national registry. Langenveld J; Ravelli AC; van Kaam AH; van der Ham DP; van Pampus MG; Porath M; Mol BW; Ganzevoort W Am J Obstet Gynecol; 2011 Dec; 205(6):540.e1-7. PubMed ID: 21907954 [TBL] [Abstract][Full Text] [Related]
5. Impact of hypertensive disorders of pregnancy on respiratory outcomes in extremely and very preterm infants: A population-based study in Japan. Ushida T; Nakamura N; Nakatochi M; Kobayashi Y; Sato Y; Iitani Y; Imai K; Nakano-Kobayashi T; Hayakawa M; Kajiyama H; Kotani T; Pregnancy Hypertens; 2022 Aug; 29():54-60. PubMed ID: 35750024 [TBL] [Abstract][Full Text] [Related]
7. Antenatal corticosteroid therapy in premature infants. Smrcek JM; Schwartau N; Kohl M; Berg C; Geipel A; Krapp M; Diedrich K; Ludwig M Arch Gynecol Obstet; 2005 Jan; 271(1):26-32. PubMed ID: 15309401 [TBL] [Abstract][Full Text] [Related]
8. Incidence of respiratory distress syndrome. Ghafoor T; Mahmud S; Ali S; Dogar SA J Coll Physicians Surg Pak; 2003 May; 13(5):271-3. PubMed ID: 12757676 [TBL] [Abstract][Full Text] [Related]
9. Respiratory distress syndrome after elective caesarean section in near term infants: a 5-year cohort study. Berthelot-Ricou A; Lacroze V; Courbiere B; Guidicelli B; Gamerre M; Simeoni U J Matern Fetal Neonatal Med; 2013 Jan; 26(2):176-82. PubMed ID: 23013109 [TBL] [Abstract][Full Text] [Related]
10. Neonatal outcome associated with singleton birth at 34-41 weeks of gestation. Gouyon JB; Vintejoux A; Sagot P; Burguet A; Quantin C; Ferdynus C; Int J Epidemiol; 2010 Jun; 39(3):769-76. PubMed ID: 20304783 [TBL] [Abstract][Full Text] [Related]
11. Preterm infant outcomes in New South Wales and the Australian Capital Territory. Bolisetty S; Legge N; Bajuk B; Lui K; J Paediatr Child Health; 2015 Jul; 51(7):713-21. PubMed ID: 25644196 [TBL] [Abstract][Full Text] [Related]
12. Antenatal corticosteroids and preterm offspring outcomes in hypertensive disorders of pregnancy: A Japanese cohort study. Ushida T; Kotani T; Hayakawa M; Hirakawa A; Sadachi R; Nakamura N; Moriyama Y; Imai K; Nakano-Kobayashi T; Kikkawa F Sci Rep; 2020 Jun; 10(1):9312. PubMed ID: 32518309 [TBL] [Abstract][Full Text] [Related]
13. Circulating anti-angiogenic factors during hypertensive pregnancy and increased risk of respiratory distress syndrome in preterm neonates. Wang A; Holston AM; Yu KF; Zhang J; Toporsian M; Karumanchi SA; Levine RJ J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1447-52. PubMed ID: 22097923 [TBL] [Abstract][Full Text] [Related]
14. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Ventolini G; Neiger R; Mathews L; Adragna N; Belcastro M Am J Perinatol; 2008 Feb; 25(2):79-83. PubMed ID: 18188800 [TBL] [Abstract][Full Text] [Related]
15. Multiple courses of antenatal corticosteroid therapy in patients with preterm premature rupture of membranes. Yang SH; Choi SJ; Roh CR; Kim JH J Perinat Med; 2004; 32(1):42-8. PubMed ID: 15008385 [TBL] [Abstract][Full Text] [Related]
16. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant. Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752 [TBL] [Abstract][Full Text] [Related]
17. Adverse respiratory outcome after premature rupture of membranes before viability. Verspyck E; Bisson V; Roman H; Marret S Acta Paediatr; 2014 Mar; 103(3):256-61. PubMed ID: 24175963 [TBL] [Abstract][Full Text] [Related]
18. Comparisons of mortality and pre-discharge respiratory outcomes in small-for-gestational-age and appropriate-for-gestational-age premature infants. Sharma P; McKay K; Rosenkrantz TS; Hussain N BMC Pediatr; 2004 Jun; 4():9. PubMed ID: 15186501 [TBL] [Abstract][Full Text] [Related]
19. Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study. Burguet A; Kaminski M; Truffert P; Menget A; Marpeau L; Voyer M; Roze JC; Escande B; Cambonie G; Hascoet JM; Grandjean H; Breart G; Larroque B; Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F41-5. PubMed ID: 15613572 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for respiratory distress syndrome among high-risk early-term and full-term deliveries. Gould AJ; Ding JJ; Recabo O; Has P; Savitz DA; Danilack VA; Lewkowitz AK J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10401-10405. PubMed ID: 36210090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]